Severe perinatal hemolytic disease due to anti-e
Paid access
|Jun 2021References
- deHaas M, Thurik FF, Koelewijn JM, van der Schoot CE. Haemolytic disease of the fetus and newborn. Vox Sang 2015;109:99–113.
- Fung MK, Eder AF, Spitalnik S, Westhoff CM, Eds. Technical manual. 19th ed. Bethesda, MD: AABB, 2017.
- Gassner C, Schmarda A, Kilga-Nogler S, et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997;37:1020–6.
- Alfonso ME, Muñiz E, Bencomo AA, et al. Aloinmunización contra células sanguíneas en el primer trimestre del embarazo. Rev Cubana Hematol Immunol Hemoter. 2006 May–August; 22. Available from http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892006000200006&lng=es. Accessed 16 March 2021.
- Alfonso ME, Muñíz E, Bencomo AA, et al. Aloanticuerpos contra células sanguíneas en embarazadas nulíparas antes y después de abortos provocados. Rev Cubana Hematol Inmunol Hemoter. 2008 May–August; 24. Available from http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892008000200007&lng=es. Accessed 16 March 2021.
- McAdams RM, Dotzler SA, Winter LW, Kerecman JD. Severe hemolytic disease of the newborn from anti-e. J Perinatol 2008;28:230–32.
- Eder AF. Update on HDFN: new information on long-standing controversies. Immunohematology 2006;22:188–95.
- Bencomo AA, Alfonso Y, Alfonso ME, González R, Martínez M. Frecuencia de los grupos sanguíneos ABO y Rh endonantes de sangrecubanos. Rev Argent Transfus 1997;23:20–1.
- Daniels G, Ed. Rh and RHAG blood group system. In: Human bloodgroups. 3rd ed. Oxford: Blackwell Scientific, 2013: 182–258.
- Chapman J, Waters AH. Haemolytic disease of the newborn due to Rhesus anti-e antibody. Vox Sang 1981;41:45–7.
- Ali HA, Zohud OS. Hemolytic disease of the newborn due to anti e. J Clin Neonatol 2002;9:146–8.
- Karagol BS, Zenciroglu A, Okumus N, Karadag N, Dursun A, Hakan N. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre. Am J Perinatol 2012;29:449–54.
- Hanzlick RL, Senhauser DA. Subclinical hemolytic disease of the newborn due to anti-e. Am J Clin Pathol 1979;72:76–9.
- American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
- Firan M, Bawdon R, Radu C, et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int Immunol 2001;13:993–1002.
- Rath ME, Smits-Wintjens VE, Walther FJ, Lopriore E. Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Hum Dev 2011;87:583–8.
- AuBuchon JP, de Wildt-Eggen J, Dumont LJ. Reducing the variation in performance of antibody titrations. Arch Pathol Lab Med 2008;132:1194–201
- Delaney M, Matthews DC. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program 2015;2015: 146–51.
- Sharma D, Dannapuneni N, Murki S, Pratap T. Combined anti e and anti C Rh isoimmunisation and severe hyperbilirubinemia. Indian J Pediatr 2015;82:570.
DOI: https://doi.org/10.21307/immunohematology-2021-011 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 72 - 77
Published on: Jun 25, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 G. Soler-Noda, Y. Romero-Díaz, L. Orbeal-Aldama, S. Aquino-Rojas, published by American National Red Cross
This work is licensed under the Creative Commons License.